125 related articles for article (PubMed ID: 1884369)
1. Preclinical evaluation of a positron emitting progestin ([18F]fluoro-16 alpha-methyl-19-norprogesterone) for imaging progesterone receptor positive tumours with positron emission tomography.
Verhagen A; Luurtsema G; Pesser JW; de Groot TJ; Wouda S; Oosterhuis JW; Vaalburg W
Cancer Lett; 1991 Aug; 59(2):125-32. PubMed ID: 1884369
[TBL] [Abstract][Full Text] [Related]
2. 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone: synthesis and target tissue selective uptake of a progestin receptor based radiotracer for positron emission tomography.
Pomper MG; Katzenellenbogen JA; Welch MJ; Brodack JW; Mathias CJ
J Med Chem; 1988 Jul; 31(7):1360-3. PubMed ID: 3260285
[TBL] [Abstract][Full Text] [Related]
3. A fluorine-18 labeled progestin as an imaging agent for progestin receptor positive tumors with positron emission tomography.
Verhagen A; Elsinga PH; de Groot TJ; Paans AM; de Goeij CJ; Sluyser M; Vaalburg W
Cancer Res; 1991 Apr; 51(7):1930-3. PubMed ID: 2004378
[TBL] [Abstract][Full Text] [Related]
4. Assessment of 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas.
Dehdashti F; McGuire AH; Van Brocklin HF; Siegel BA; Andriole DP; Griffeth LK; Pomper MG; Katzenellenbogen JA; Welch MJ
J Nucl Med; 1991 Aug; 32(8):1532-7. PubMed ID: 1869974
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of a [18F]fluorine labeled progestin (21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone) in humans: a clue for future investigations.
Verhagen A; Studeny M; Luurtsema G; Visser GM; De Goeij CC; Sluyser M; Nieweg OE; Van der Ploeg E; Go KG; Vaalburg W
Nucl Med Biol; 1994 Oct; 21(7):941-52. PubMed ID: 9234348
[TBL] [Abstract][Full Text] [Related]
6. Fluorine-18-labeled progestin 16 alpha, 17 alpha-dioxolanes: development of high-affinity ligands for the progesterone receptor with high in vivo target site selectivity.
Buckman BO; Bonasera TA; Kirschbaum KS; Welch MJ; Katzenellenbogen JA
J Med Chem; 1995 Jan; 38(2):328-37. PubMed ID: 7830275
[TBL] [Abstract][Full Text] [Related]
7. PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.
Jonson SD; Welch MJ
Q J Nucl Med; 1998 Mar; 42(1):8-17. PubMed ID: 9646640
[TBL] [Abstract][Full Text] [Related]
8. Fluorine-18-labeled progestin ketals: synthesis and target tissue uptake selectivity of potential imaging agents for receptor-positive breast tumors.
Kochanny MJ; VanBrocklin HF; Kym PR; Carlson KE; O'Neil JP; Bonasera TA; Welch MJ; Katzenellenbogen JA
J Med Chem; 1993 Apr; 36(9):1120-7. PubMed ID: 8487253
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and organ distribution of [18F]fluoro-Org 6141 in the rat: a potential glucocorticoid receptor ligand for positron emission tomography.
Visser GM; Krugers HJ; Luurtsema G; van Waarde A; Elsinga PH; deKloet ER; Groen MB; Bohus B; Go KG; Paans AM
Nucl Med Biol; 1995 Oct; 22(7):915-20. PubMed ID: 8547889
[TBL] [Abstract][Full Text] [Related]
10. New iodinated progestins as potential ligands for progesterone receptor imaging in breast cancer. Part 2: In vivo pharmacological characterization.
Rijks LJ; van den Bos JC; van Doremalen PA; Boer GJ; de Bruin K; Janssen AG; van Royen EA
Nucl Med Biol; 1998 Nov; 25(8):791-8. PubMed ID: 9863568
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of [18F]fluoroalanine and [18F]fluorotamoxifen for imaging breast tumors.
Yang D; Kuang LR; Cherif A; Tansey W; Li C; Lin WJ; Liu CW; Kim EE; Wallace S
J Drug Target; 1993; 1(3):259-67. PubMed ID: 8069568
[TBL] [Abstract][Full Text] [Related]
12. Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography.
Lee JH; Zhou HB; Dence CS; Carlson KE; Welch MJ; Katzenellenbogen JA
Bioconjug Chem; 2010 Jun; 21(6):1096-104. PubMed ID: 20496889
[TBL] [Abstract][Full Text] [Related]
13. Impact on estrogen receptor binding and target tissue uptake of [18F]fluorine substitution at the 16alpha-position of fulvestrant (faslodex; ICI 182,780).
Seimbille Y; Bénard F; Rousseau J; Pepin E; Aliaga A; Tessier G; van Lier JE
Nucl Med Biol; 2004 Aug; 31(6):691-8. PubMed ID: 15246359
[TBL] [Abstract][Full Text] [Related]
14. Progestin radiopharmaceuticals labeled with technetium and rhenium: synthesis, binding affinity, and in vivo distribution of a new progestin N2S2-metal conjugate.
O'Neil JP; Carlson KE; Anderson CJ; Welch MJ; Katzenellenbogen JA
Bioconjug Chem; 1994; 5(3):182-93. PubMed ID: 7918738
[TBL] [Abstract][Full Text] [Related]
15. 16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors.
VanBrocklin HF; Carlson KE; Katzenellenbogen JA; Welch MJ
J Med Chem; 1993 May; 36(11):1619-29. PubMed ID: 7684451
[TBL] [Abstract][Full Text] [Related]
16. The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer.
Katzenellenbogen JA; Welch MJ; Dehdashti F
Anticancer Res; 1997; 17(3B):1573-6. PubMed ID: 9179196
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of 17-ethynyl-substituted 16 alpha-[18F]fluoroestradiols: selective receptor-based PET imaging agents.
VanBrocklin HF; Pomper MG; Carlson KE; Welch MJ; Katzenellenbogen JA
Int J Rad Appl Instrum B; 1992 Apr; 19(3):363-74. PubMed ID: 1629026
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of [18F]fluoro-labeled progestins for PET.
de Groot TJ; Verhagen A; Elsinga PH; Vaalburg W
Int J Rad Appl Instrum A; 1991; 42(5):471-4. PubMed ID: 1646193
[TBL] [Abstract][Full Text] [Related]
19. 6 alpha-[18F]fluoroprogesterone: synthesis via halofluorination-oxidation, receptor binding and tissue distribution.
Choe YS; Bonasera TA; Chi DY; Welch MJ; Katzenellenbogen JA
Nucl Med Biol; 1995 Jul; 22(5):635-42. PubMed ID: 7581174
[TBL] [Abstract][Full Text] [Related]
20. Oxohexestrol derivatives labeled with fluorine-18. Synthesis, receptor binding and in vivo distribution of two non-steroidal estrogens as potential breast tumor imaging agents.
Bergmann KE; Landvatter SW; Rocque PG; Carlson KE; Welch MJ; Katzenellenbogen JA
Nucl Med Biol; 1994 Jan; 21(1):25-39. PubMed ID: 9234261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
